Veoza, also known as fezolinetant, is prescription-only and will be available privately from January
A “gamechanging” drug that prevents hot flushes and could benefit hundreds of thousands of women has been approved for use in the UK.
The green light for Veoza, also known as fezolinetant, comes after the US regulator, the Food and Drug Administration, authorised it for use in America in May.
More Stories
Virologist Wendy Barclay: ‘Wild avian viruses are mixing up their genetics all the time. It’s like viral sex on steroids’
Microsoft unveils chip it says could bring quantum computing within years
I keep fantasising about living in total solitude in a forest